| Robeson Family Vision Center | |
|
1400 Homer Rd Winona MN 55987-6044 | |
| (507) 454-4092 | |
| (507) 454-5384 |
| Full Name | Robeson Family Vision Center |
|---|---|
| Speciality | Clinic/Center |
| Location | 1400 Homer Rd, Winona, Minnesota |
| Authorized Official Name and Position | Lane C Robeson (PRESIDENT) |
| Authorized Official Contact | 5074544092 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Robeson Family Vision Center 1400 Homer Rd Winona MN 55987-6044 Ph: (507) 454-4092 | Robeson Family Vision Center 1400 Homer Rd Winona MN 55987-6044 Ph: (507) 454-4092 |
| NPI Number | 1407082837 |
|---|---|
| Provider Enumeration Date | 05/29/2009 |
| Last Update Date | 07/09/2010 |
| Medicare PECOS PAC ID | 5496801656 |
|---|---|
| Medicare Enrollment ID | O20090914000453 |
News Archive
Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
Unless someone can drop into Anthony Kennedy's dreamspace and, "Inception"-style, either figure out what he thinks of the individual mandate or simply tell him what to think of the individual mandate, it's not worth spending much time speculating on the ultimate legal fate of the provision. The case will eventually make its way to the Supreme Court, and when it does, Kennedy will decide which side has the majority, and until that happens, the various legal decisions are little different from op-ed columns (Ezra Klein, 12/18).
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407082837 | NPI | - | NPPES |
| Provider Name | Lane C Robeson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1891762282 PECOS PAC ID: 1052205457 Enrollment ID: I20040209000294 |
News Archive
Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
Unless someone can drop into Anthony Kennedy's dreamspace and, "Inception"-style, either figure out what he thinks of the individual mandate or simply tell him what to think of the individual mandate, it's not worth spending much time speculating on the ultimate legal fate of the provision. The case will eventually make its way to the Supreme Court, and when it does, Kennedy will decide which side has the majority, and until that happens, the various legal decisions are little different from op-ed columns (Ezra Klein, 12/18).
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
| Provider Name | Robin E Theye |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1750544383 PECOS PAC ID: 9638246770 Enrollment ID: I20101115000621 |
News Archive
Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
Unless someone can drop into Anthony Kennedy's dreamspace and, "Inception"-style, either figure out what he thinks of the individual mandate or simply tell him what to think of the individual mandate, it's not worth spending much time speculating on the ultimate legal fate of the provision. The case will eventually make its way to the Supreme Court, and when it does, Kennedy will decide which side has the majority, and until that happens, the various legal decisions are little different from op-ed columns (Ezra Klein, 12/18).
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
News Archive
Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.
When Speaker Nancy Pelosi unveiled the revised House Democratic health care bill last week, the Obama White House hailed it as a "critical milestone" in the process. No doubt senior administration officials were relieved to see signs of "momentum" toward passage of something. But if the president really meant what he has said about health care policy throughout this year, his administration would be working to defeat the Pelosi bill, not supporting it (James Capretta).
Honing chemotherapy delivery to cancer cells is a challenge for many researchers. Getting the cancer cells to take the chemotherapy "bait" is a greater challenge. But perhaps such a challenge has not been met with greater success than by the nanotechnology research team of Omid Farokhzad, MD, Brigham and Women's Hospital (BWH) Department of Anesthesiology Perioperative and Pain Medicine and Research.
Unless someone can drop into Anthony Kennedy's dreamspace and, "Inception"-style, either figure out what he thinks of the individual mandate or simply tell him what to think of the individual mandate, it's not worth spending much time speculating on the ultimate legal fate of the provision. The case will eventually make its way to the Supreme Court, and when it does, Kennedy will decide which side has the majority, and until that happens, the various legal decisions are little different from op-ed columns (Ezra Klein, 12/18).
Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.
› Verified 7 days ago
Woolley Chiropractic Center Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3930 W 6th St, Winona, MN 55987 Phone: 507-452-4490 | |
Winona Clinic Ltd Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-454-3680 Fax: 507-457-7672 | |
Winona Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-454-3680 | |
Winona Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-457-4521 Fax: 507-474-3284 | |
Family Medicine Of Winona P.a. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 825 Mankato Ave Ste 210, Winona, MN 55987 Phone: 507-454-5050 Fax: 507-454-5102 | |
Winona Health Services Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 855 Mankato Ave, Winona, MN 55987 Phone: 507-454-3650 Fax: 507-457-4413 | |
Winona Health Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 859 Mankato Ave, Winona, MN 55987 Phone: 507-457-4570 Fax: 507-474-3284 |